Navigation Links
Malaria vaccine candidate, RTS,S reduces the risk of malaria by half in African children
Date:10/18/2011

CHAPEL HILL, N.C. First results from a large-scale Phase III trial of RTS,S*, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.

Half the world's population is at risk of malaria. The disease is responsible for close to 800,000 deaths each year, most of whom are children under five in sub-Saharan Africa

5 to 17 month-old children

The trial, conducted at 11 trial sites in seven countries across sub-Saharan Africa, including a UNC-led site in Lilongwe, Malawi, showed that three doses of RTS,S reduced the risk of children experiencing clinical malaria and severe malaria by 56 percent and 47 percent, respectively. This analysis was performed on data from the first 6,000 children aged 5 to 17 months, over a 12-month period following vaccination. Clinical malaria results in high fevers and chills. It can rapidly develop into severe malaria, typified by serious effects on the blood, brain, or kidneys that can prove fatal. These first Phase III results are in line with those from previous Phase II studies.

The widespread coverage of insecticide-treated bed nets (75 percent) in this study indicated that RTS,S can provide protection in addition to that already offered by existing malaria control interventions.

6 to 12 week-old infants

The trial is ongoing and efficacy and safety results in 6 to 12 week-old infants are expected by the end of 2012. These data will provide an understanding of the efficacy profile of the RTS,S malaria vaccine candidate in this age group, for both clinical and severe malaria.

Combined data in 6 to 12 week-old infants and 5 to 17
'/>"/>

Contact: Lisa Chensvold
lisa_chensvold@med.unc.edu
919-843-5719
University of North Carolina School of Medicine
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Malaria elimination maps highlight progress and prospects
2. Modified vaccine shows promise in preventing malaria
3. New treatment for kala azar, the most deadly parasitic disease after malaria
4. Whole-parasite malaria vaccine shows promise in University of Maryland School of Medicine clinical trial
5. Malaria parasites camouflage themselves from the immune defenses of expectant mothers
6. Targeting innate immunity in malaria
7. Major malaria drug research award
8. Researchers discover biochemical weakness of malaria parasite -- vaccine to be developed
9. UT Southwestern research teams anti-malarial work wins international Project of the Year award
10. Gates Foundation awards Ben-Gurion U. researcher grant for malaria detection using cell phones
11. EPO doping helps combat cerebral malaria
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Malaria vaccine candidate, RTS,S reduces the risk of malaria by half in African children
(Date:5/24/2013)... Scott Ryan Tischler of Tischler Brothers ... 200 lbs. of fat in just over a year. ... brother the importance of exercising. Scott also taught Troy ... these 7 rules of healthy eating and having a ... accomplished. , 1.    Find a distraction when a food craving ...
(Date:5/24/2013)... The leading retail brand Short Dresses has recently ... . Now that is quite unbelievable, especially in view of ... since its origin. The retailer has already revealed its wider ... discount offer will be an added bonanza for the frequent ... announce that Short Dresses is to offer different levels of ...
(Date:5/23/2013)... 2013 Magnatag’s new magnetic 365-Day attendance ... reduces vacation conflicts. A Manufacturing Manager from Augusta GA ... now employees and managers can check the board for ... is important to us and the board makes the ... seem harsh but it has made a difference.” ...
(Date:5/23/2013)... May 24, 2013 Sublime Beauty® ... Cellulite Whisperer line, with a 35% discount ... Sale" includes two proprietary products, the Cellulite ... . , Purchasers receive a report "Getting Control ... Gel has a wonderful grapefruit scent," says Kathy ...
(Date:5/23/2013)... High blood glucose is associated with poor outcomes in ... to control hyperglycemia is a common practice in hospitals. ... benefit and even shows harms associated with the use ... (ACP) Clinical Guidelines Committee in a new evidence-based paper ... Medical Quality . , "Clinicians caring for hospitalized patients ...
Breaking Medicine News(10 mins):Health News:short prom dresses Offers Abnormally Low Discount on Its New Collections 2Health News:New Attendance, Vacation and Training Tracker Board Reduces Employee Conflicts and Improves Attendance 2Health News:Fresh Organics in the New Cellulite Whisperer® Products from Sublime Beauty®; "Get Ready for Summer Sale" Continues 2Health News:ACP issues recommendations for management of high blood glucose in hospitalized patients 2
... -- Rice University scientists have captured the first optical ... fruit flies, the researchers confirmed that a technique developed ... of detecting DNA-sized nanotubes inside living fruit flies. , ... they give off fluorescent light in a way that ...
... and sports injury treatment but limitations with current calibration ... that could lead to further injury. New technology developed ... tested by Lothian NHS could greatly improve the accuracy ... , NPL has developed an acoustic ...
... is ,Bold and Visionary, says Global AIDS Alliance Fund, ... Senator John Edwards is announcing a new proposal,for what ... in the US and abroad., To address the ... in resources to reach universal access to prevention and,treatment. ...
... Consumers to ... Beware!, OMAHA, ... Cosmetic Dermatology and Aesthetic,Surgery (ASCDAS), responded to the recent decision by Judge ... Arts to ban the,liposuction treatment, Lipodissolve. "This procedure is still unsafe in ...
... be successful, PITTSBURGH, Sept. 24 For ... be the path to becoming smoke-free. While,there are ... a new national,survey conducted by Nicorette Cinnamon Surge ... an advance plan.(1) In fact, half (49,percent) of ...
... 24 Wyeth (NYSE: WYE ),today kicks off ... and manufacturing facility, honoring the generations of employees,at the ... science,and human health. The 550-acre complex, located in ... employs approximately 3,200 people and is one of,the largest ...
Cached Medicine News:Health News:Scientists get first look at nanotubes inside living animals 2Health News:New acoustic absorber to improve physiotherapy ultrasound machines 2Health News:Edwards' Plan on AIDS Unveiled Today 2Health News:Lipodissolve - Is it Safe??? 2Health News:Photos: New Survey Shows Many Successful Quit Smoking Attempts Made Without Advance Planning 2Health News:Photos: New Survey Shows Many Successful Quit Smoking Attempts Made Without Advance Planning 3Health News:Photos: New Survey Shows Many Successful Quit Smoking Attempts Made Without Advance Planning 4Health News:Wyeth's Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health care 2Health News:Wyeth's Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health care 3Health News:Wyeth's Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health care 4
(Date:5/23/2013)... May 23, 2013  Ameritox, the nation,s leader ... Progressive Medical, Inc. to become part of its ... manage pharmacy costs and improve the clinical outcomes ... leading pharmacy benefit manager in the workers, compensation ... compliance and pain management strategy for several years. ...
(Date:5/23/2013)... Md. , May 23, 2013  BioElectronics Corporation ... consumer medical devices, comments on the FDA panel meeting ... Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting was ... MD , USA.  The focus of the meeting ... the panel to focus solely on the application of ...
(Date:5/23/2013)... 2013  CAS Medical Systems, Inc. (NASDAQ: CASM ... monitoring, today announced that Thomas M. Patton ... 2 nd Annual Marcum MicroCap Conference on Thursday, May ... New York City . The presentation is ... 10 room and will be available via a live webcast ...
Breaking Medicine Technology:Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2
... Dr. Rolf Badenhoop M.D., a 20-year veteran of the ... sales and marketing consulting firm ZS Associates ... Frankfurt office. "I am excited to work ... better understand and respond to business challenges posed by ...
... VOLC ) today announced its intention to offer, ... amount of convertible senior notes due September 1, 2015 in ... amended (the "Securities Act"). Prior to June 1, 2015, the ... holders will receive up to the principal amount of the ...
Cached Medicine Technology:ZS Associates Appoints Pharmaceutical Industry Veteran to Serve the Firm's Growing Client Base in Germany 2Volcano Corporation to Offer $100 Million Convertible Senior Notes Due 2015 2Volcano Corporation to Offer $100 Million Convertible Senior Notes Due 2015 3Volcano Corporation to Offer $100 Million Convertible Senior Notes Due 2015 4
... The Anti-HCV Low Titer Performance Panel ... from weak to strong positive for antibodies ... is intended for use by manufacturers and ... Comprehensive data from all major test systems ...
... Panel consists of plasma specimens with reactivity ... antibodies to the Hepatitis C Virus., This ... manufacturers and clinical laboratories to evaluate their ... all major test systems are included for ...
... POPmesh is a ... that can be used ... pelvic floor procedures, including ... prolapse. Supple yet strong, ...
Suspend® Tutoplast® Processed Fascia Lata is your naturally safe and strong choice for pelvic floor reconstruction. Suspend comes from a dense matrix of collagen bundles and transverse fasc...
Medicine Products: